Literature DB >> 6216412

Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2.

M Malkovsky, G L Asherson, B Stockinger, M C Watkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6216412     DOI: 10.1038/300652a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  26 in total

1.  Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections.

Authors:  M Wallace; A M Scharko; C D Pauza; P Fisch; K Imaoka; S Kawabata; K Fujihashi; H Kiyono; Y Tanaka; B R Bloom; M Malkovsky
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

Review 2.  The interleukins in acquired disease.

Authors:  M Malkovský; P M Sondel; W Strober; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

3.  Serum IL-2 inhibitor in mice. II. Molecular characteristics.

Authors:  D Male; R Lelchuk; S Curry; G Pryce; J H Playfair
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

4.  Acquired immunodeficiency with disseminated cryptococcosis.

Authors:  M J Pippard; A Dalgleish; P Gibson; M Malkovsky; A D Webster
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

5.  Non-specific inhibitor made by T acceptor cells inhibits both the afferent and efferent stage of the contact sensitivity reaction.

Authors:  M A Zembala; V Colizzi; G L Asherson; M C Watkins
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

6.  In vivo gammadelta T cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands.

Authors:  F Poccia; M Malkovsky; A Pollak; V Colizzi; G Sireci; A Salerno; F Dieli
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

7.  Serum IL-2 inhibitor in mice. I. Increase during infection.

Authors:  R Lelchuk; J H Playfair
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

8.  A non-specific inhibitor produced by Candida albicans activated T cells impairs cell proliferation by inhibiting interleukin-1 production.

Authors:  G Lombardi; D Vismara; E Piccolella; V Colizzi; G L Asherson
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

9.  Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice.

Authors:  A Hoffenbach; P H Lagrange; M A Bach
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

10.  In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.

Authors:  V Colizzi
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.